Shapiro, A. D. (2021). Concizumab: A novel anti-TFPI therapeutic for hemophilia. Blood Adv.
Chicago ZitierstilShapiro, Amy D. "Concizumab: A Novel Anti-TFPI Therapeutic for Hemophilia." Blood Adv 2021.
MLA ZitierstilShapiro, Amy D. "Concizumab: A Novel Anti-TFPI Therapeutic for Hemophilia." Blood Adv 2021.
Achtung: Diese Zitate sind unter Umständen nicht zu 100% korrekt.